Bold Science Breaks Through
This is where progress is earned. Across labs and clinical trials, our teams work tirelessly to discover and develop new treatments for serious diseases. We keep pushing forward when the stakes are this real.
Bold Science Breaks Through
This is where progress is earned. Across labs and clinical trials, our teams work tirelessly to discover and develop new treatments for serious diseases. We keep pushing forward when the stakes are this real.
Where discovery
becomes
treatment
This is the work behind every breakthrough.
Science Firsthand shows what it takes to turn discovery into treatment. Through the voices of Bristol Myers Squibb’s R&D leaders, it reveals how bold ideas, persistence and collaboration drive progress for patients.
Science Firsthand Video
Science Firsthand
BMS Research & Development
Senior Vice President, Neuroscience, Immunology, Integrative Sciences and Cardiovascular Research
Scientists are inherently curious, and they’re persistent. Breakthroughs don’t always happen easily, but scientists are resilient.
Senior Vice President, Protein Homeostasis Research
New modalities do not come along very often. And so when they do, there is great promise. It’s one of the main motivations for our BMS scientists to push the limits, rapidly iterate, and drive forward novel medicines for patients who need them most.
Vice President, Discovery Biotherapeutics, Lead Development and Optimization
Typically, drug discovery timelines have been on the scale of decades, and it has been incredibly hard to truncate those timelines. Being able to leverage predictive molecule invention upfront allows us to accelerate drug discovery in a way that increases our chances of progressing the best molecules.
Senior Vice President, Informatics and Predictive Sciences
We have tested many hypotheses in the clinic, and many of those have failed. But with each hypothesis we test, we learn something. We learn about human causal biology — the root cause of disease — or about the targets and medicines we’ve tested.
Senior Vice President, Translational Medicine, Clinical Pharmacology and Cell Therapy Research
There are a lot of jobs where you go to work every day, work really hard, and you’re not sure what the final outcome will be. In clinical trials, the outcome is very measurable. When I look at a trial I worked on and see that there are still patients in a complete response, it’s an incredibly gratifying and fulfilling feeling.
Innovation Moves
our Science Forward
Progress takes all of us. We combine science, digital and AI to move faster and bring medicines closer to patients.
As of February 5, 2026
Our pipeline targets areas where we can deliver transformative medicines—faster—for patients who need them most.
Discover our pipeline
As of February 5, 2026
Our pipeline targets areas where we can deliver transformative medicines—faster—for patients who need them most.
Discover our pipeline
Trials within
reach
Innovation begins long before a medicine reaches patients. It starts with new ideas, new technologies, and new ways to understand disease. From earlier detection and smarter diagnostics to advanced research and global partnerships, we’re finding better ways to see clearly, learn faster, and act sooner.
Frequently
Asked Questions
Find answers to common questions about how Bristol Myers Squibb advances science and innovation to deliver meaningful progress for patients.
At BMS, bold science begins with a deep understanding of disease biology and progresses through a rigorous research and development process. From early discovery through clinical development, scientific insights are translated into potential new medicines designed to make a meaningful difference for patients.
Digital, data and artificial intelligence (AI) are central to how BMS advances research and drug development, helping our teams decode complex human biology, accelerate clinical trials and improve the probability that our most promising ideas translate into transformational medicines that benefit patients. By integrating AI with deep domain expertise and proprietary data, we’re working to ensure more high-quality medicines reach patients faster.
Research at BMS moves from laboratory discovery into clinical research, where potential new medicines are studied in clinical trials. These trials help determine safety and effectiveness and are a critical step in advancing new therapies toward patient care.
The BMS pipeline focuses on core therapeutic areas highlighted in its research strategy, including oncology, hematology, immunology, cardiovascular disease and neuroscience. To learn more, visit bms.com.
Clinical trials are essential to evaluating new medicines and may provide patients with access to investigational treatment options. They also help advance scientific knowledge that can benefit future patients.